The nurse is discussing the current use of genetic testing and tamoxifen with a client who has breast cancer.Which information should the nurse include in this discussion?
A) The United States Agency of Healthcare Research and Quality recommends genetic testing for clients starting tamoxifen.
B) Insurance providers in the United States do not support the use of CYP2D6 testing prior to prescribing tamoxifen.
C) Dutch researchers support CYP2D6 testing prior to prescribing tamoxifen.
D) Some European groups recommend using medications other than tamoxifen for women whose CYP2D6 testing reveals intermediate metabolizer status.
E) Recommendations from across the globe vary as to the benefit of genetic testing prior to prescribing tamoxifen.
Correct Answer:
Verified
Q2: A client who has been taking warfarin
Q3: A client was prescribed warfarin starting last
Q4: Which client question reveals a primary ethical
Q5: Which way of encouraging use of pharmacogenetic
Q6: A client is having genetic testing done
Q8: Which statement by a newly licensed nurse
Q9: The prescriber who follows the latest research
Q10: The nurse is evaluating the appropriateness of
Q11: The nurse will be responsible for the
Q12: A client asks the nurse how something
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents